Optetrak 200-21-11Recalls & reported problems
Exactech, Inc. · Class 2 · Implant
All models of Optetrak (336)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10885862040152), received between Mar 27, 2024 and Jun 9, 2026 — classified as 2 injuries.
The most frequently reported specific device problem is “Naturally Worn” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
2 other recalls cover devices cleared under the same FDA submission (K932776); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Aug 30, 2021Class IIOpen, Classified
Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.
Z-0019-2022 · Root cause: Process control · Recall details · FDA record ↗
Most reported problems
Device problems
- Naturally Worn2
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Pain2
- Fall1
- Implant Pain1
- Osteolysis1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJun 9, 2026Naturally Worn
REPORT #3 OF 3 FOR THIS EVENT. AS REPORTED BY LEGAL DOCUMENTATION, A PATIENT UNDERWENT A LEFT TOTAL KNEE ARTHROPLASTY. SUBSEQUENTLY, APPROXIMATELY TEN (10) YEARS LATER, THE PATIENT PRESENTED TO SURGEON COMPLAINING OF PAIN UNRELATED TO INJURY/WORK INJURY. PATIENT REPORTS 8 OUT OF 10 ON PAIN SCALE IN LEFT AND RIGHT KNEES. ONGOING INTERMITTENT ACHING. GRADUALLY WORSENING. AGGRAVATED BY: BENDING, STRETCHING, STRAIGHTENING, EXERCISE, KNEELING, SQUATTING, STANDING, WALKING, STAIRS. PATIENT REPORTED FALLING ON BOTH KNEES WHILE WALKING THE DOG. RADIOGRAPHS, PER THE SURGEON APPEARS TO DEMONSTRATE LUCENCY ABOUT THE TIBIAL PLATEAU COMPONENT OF THE PROSTHESIS AND FEMORAL COMPONENT OF THE PROSTHESIS ON THE LEFT THAT MAY REPRESENT LOOSENING. MEDICAL RECORDS AND CLINICAL HISTORY WERE PROVIDED. IT IS UNKNOWN IF THE PATIENT UNDERWENT REVISION OF THE LEFT KNEE OR IF A LEFT KNEE REVISION IS PLANNED OR SCHEDULED. THE PATIENT WAS REFERRED TO AN ORTHOPAEDIC SURGEON FOR CONSULTATION OF POSSIBLE REVISION. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Fall; Pain
MAUDE report 25450349 ↗InjuryMar 27, 2024Naturally Worn; Loosening of Implant Not Related to Bone-Ingrowth; Naturally Worn; Loosening of Implant Not Related to Bone-Ingrowth
IT WAS REPORTED VIA LEGAL DOCUMENTATION THAT A PATIENT HAD A TOTAL RIGHT KNEE ARTHROPLASTY ON (B)(6) 2011 AND THEN APPROXIMATELY 12 YEARS, 11 MONTHS LATER ON (B)(6) 2024 THE PATIENT HAD A SURGICAL REVISION. REVISION OPERATIVE REPORT 8 JAN 2024-POSTOPERATIVE DIAGNOSIS: ASEPTIC LOOSENING OF RIGHT TOTAL KNEE. PATIENT REVISED TO COMPETITOR'S DEVICES. PATIENT WITH RADIOGRAPHIC EVIDENCE OF ASEPTIC LOOSENING OF THE FEMORAL AND TIBIAL COMPONENTS WITH AREAS OF OSTEOLYSIS IN FEMUR AND TIBIA. NEGATIVE FOR INFECTION. THERE IS EVIDENCE OF CATASTROPHIC POLYETHYLENE WEAR WITH VISUAL DETERIORATION OF THE POLYETHYLENE WITH MULTIPLE POLYETHYLENE FRAGMENTS THROUGHOUT THE KNEE. PATELLA POLYETHYLENE COMPONENT WAS UNDERMINED WITH AREAS OF OSTEOLYSIS. THE PATIENT WAS AWAKENED AND BROUGHT TO THE RECOVERY ROOM IN STABLE CONDITION. THERE IS NO DEVICE RETURN. THERE IS NO OTHER INFORMATION PROVIDED.
Patient problems: Implant Pain; Osteolysis; Pain
MAUDE report 18985313 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K932776. One submission often covers many models, so check the product and lot details in each record.
- Z-0927-06 · Dec 19, 2005 · TerminatedProduct is Optetrak Cemented Finned Tibial Tray Sz. 4F/5T. Knee prosthesis. Product is labeled in part: ''OPTETRAK FINNED TIBIAL TRAY A/P53 mm M/L 83mm***STERILE, SINGLE USE ONL
- Z-1379-05 · Jun 2, 2005 · TerminatedThe product is a Finned Tibial Tray. Product is labeled in part: ''OPTETRAK FINNED TIBIAL TRAY A/P 53 mm ML 83mm***4F/5T Ti Alloy FITS ONLY SZ. 4 FEMORAL CEMENTED***STERILE, SING
Other Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices
- ATTUNE 1506-00-005Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER589 reports
- ATTUNE 1506-00-004Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER580 reports
- JOURNEY 74012812Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER502 reports
- JOURNEY 74011856Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER438 reports
- PERSONA™ 42-5099-094-00Zimmer, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER406 reports
- JOURNEY 74011857Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER388 reports
- ATTUNE 1506-00-007Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER288 reports
- ATTUNE 1506-00-003Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER271 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page